Catalyst Wire Dossier Catalyst Wire Dossier

Regan Tangjiang

· Beijing Da-an Bio-technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Regan Tangjiang, covering 2017-03-24 to 2017-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome [Phase 2]

See pricing